Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.

Patients on dialysis are at high risk for death due to COVID-19, yet a significant proportion do survive as evidenced by presence of SARS-CoV-2 antibodies in 8% of patients in the U.S. in July 2020. It is unclear whether patients with seropositivity represent the subgroup with robust health status,...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Shuchi, Montez-Rath, Maria E., Han, Jialin, Garcia, Pablo, Bozeman, Julie, Kerschmann, Russell, Beyer, Paul, Parsonnet, Julie, Chertow, Glenn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049224/
https://www.ncbi.nlm.nih.gov/pubmed/33857168
http://dx.doi.org/10.1371/journal.pone.0249466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049224/
https://www.ncbi.nlm.nih.gov/pubmed/33857168
http://dx.doi.org/10.1371/journal.pone.0249466

Ejemplares similares